Clinical Trial: Aspirin and PAClitaxel in Head & Neck Squamous Cell Carcinoma

U.S., Oct. 29 -- ClinicalTrials.gov registry received information related to the study (NCT07901803) titled 'Aspirin and PAClitaxel in Head & Neck Squamous Cell Carcinoma' on Oct. 22.

Brief Summary: This is a phase II trial of aspirin and paclitaxel in patients with recurrent/metastatic (R/M) Head and Neck Squamous Cell Carcinoma (HNSCC) who have received prior platinum and PD-1 inhibitor treatment and have an alteration in the PI3K pathway.

Study Start Date: Dec. 31

Study Type: INTERVENTIONAL

Condition: Head and Neck (HNSCC) Head and Neck Squamous Cell Carcinoma (HNSCC) - Recurrent/Metastatic (R/M) Head and Neck Squamous Cell Carcinoma Recurrent / Metastatic Head and Neck Squamous Cell Carcinoma

Intervention: DRUG: Aspirin

Aspirin ...